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Background: Previous research has indicated that corpus callosum atrophy is associated with global cognitive
decline in neurodegenerative diseases, but few studies have investigated specific cognitive functions.
Objective: To investigate the role of regional corpus callosum atrophy in mental speed, attention and
executive functions in subjects with age-related white matter hyperintensities (WMH).
Methods: In the Leukoaraiosis and Disability Study, 567 subjects with age-related WMH were examined with
a detailed neuropsychological assessment and quantitative magnetic resonance imaging. The relationships of
the total corpus callosum area and its subregions with cognitive performance were analysed using multiple
linear regression, controlling for volume of WMH and other confounding factors.
Results: Atrophy of the total corpus callosum area was associated with poor performance in tests assessing
speed of mental processing—namely, trail making A and Stroop test parts I and II. Anterior, but not posterior,
corpus callosum atrophy was associated with deficits of attention and executive functions as reflected by the
symbol digit modalities and digit cancellation tests, as well as by the subtraction scores in the trail making and
Stroop tests. Furthermore, semantic verbal fluency was related to the total corpus callosum area and the
isthmus subregion.
Conclusions: Corpus callosum atrophy seems to contribute to cognitive decline independently of age,
education, coexisting WMH and stroke. Anterior corpus callosum atrophy is related to the frontal-lobe-
mediated executive functions and attention, whereas overall corpus callosum atrophy is associated with the
slowing of processing speed.
C
orpus callosum is the largest commissural structure
consisting of white matter tracts that connect the cerebral
hemispheres according to an anterior–posterior topogra-
phical organisation. Recent research using diffusion tensor
magnetic resonance imaging (MRI) has augmented earlier
postmortem findings of corpus callosum topography and has
shown that the anterior parts of corpus callosum (rostrum and
genu) connect the orbitofrontal, lateral and medial frontal
cortices, whereas the body and splenium connect parietal,
temporal and occipital homotopic regions.1 In neurodegenera-
tive diseases, the corpus callosum area is markedly reduced,
indicating marked axonal loss.2–5 In Alzheimer’s disease, the
severity and pattern of corpus callosum atrophy have been
associated with cortical neuronal loss6 independently of white
matter hyperintensities (WMH).7 In vascular dementia and
other ischaemic conditions, however, corpus callosum atrophy
is correlated with WMH and hence may result from subcortical
ischaemic damage.8 9
Earlier studies have shown that corpus callosum atrophy is
associated with global cognitive status,5 6 10 but, to date, few
studies have investigated the role of regional corpus callosum
atrophy in specific cognitive processes. Based on the topogra-
phical organisation of corpus callosum, the integrity of its
subregions may reflect distinct cognitive deficits. In particular,
anterior corpus callosum atrophy may be related to the frontal-
lobe-mediated executive deficits. Previous work of the
Leukoaraiosis and Disability (LADIS) Study has shown that
age-related WMH are associated with cognitive impairment in
elderly subjects without dementia.11 Moreover, in these
subjects, the corpus callosum area has been found to be
inversely related to motor deficits and global cognitive decline.12
This study examined the independent contribution of regional
corpus callosum atrophy to deficits in mental speed, attention
and executive functions in a large sample of elderly subjects
with WMH by using quantitative MRI analysis and targeted
neuropsychological test methods. The demographic and med-
ical background variables, and coexisting WMH were controlled
by using multivariate analysis.
MATERIALS AND METHODS
Subjects and study design
The LADIS Study is a longitudinal European multicentre study
aimed at investigating the importance of age-related WMH in
transition to disability. Eleven centres in European countries
participated in the study (see the appendix), collecting a sample
of 639 elderly subjects with different degrees of WMH. Details
of the study protocol have been published earlier.13 The sample
consisted of initially non-disabled subjects without dementia
who had mild cognitive or motor disturbances, mood changes,
other neurological problems, or in whom age-related WMH
Abbreviations: CC1, rostrum and genu; CC2, rostral body; CC3,
midbody; CC4, isthmus; CC5, splenium; LADIS, Leukoaraiosis and
Disability; MMSE, Mini-Mental State Examination; MRI, magnetic
resonance imaging; VADAS-cog, Vascular Dementia Assessment Scale—
Cognitive; WMH, white matter hyperintensities
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were found incidentally in brain imaging. Controls and
volunteers from other study projects were also included. The
inclusion criteria were as follows: age 65–84 years, changes in
cerebral subcortical white matter (from mild to severe accord-
ing to a revised version of the scale of Fazekas et al13), no or mild
impairment in instrumental activities of daily living (none or
one item compromised in this scale13a) and presence of a
contactable informant. The exclusion criteria were: presence of
severe illness likely leading to drop-out, severe unrelated
neurological disease, leucoencephalopathy of non-vascular
origin (immunological-demyelinating, metabolic, toxic, infec-
tious or other), severe psychiatric disorders, and inability or
refusal to undergo brain MRI. The study was approved by the
local ethics committees of each participating centre. Informed
written consent was received from all subjects. In all, 72
subjects were excluded from this study because MRI data of
WMH or corpus callosum were incomplete (the dataset was not
completed or the scans were of insufficient quality for
quantitative analysis). The total sample in this study was
therefore 567 subjects. The included and excluded subjects did
not differ from each other in age, sex, education, history of
stroke, the visual WMH rating or the Mini-Mental State
Examination score.14
The baseline assessment on study entry included brain MRI
and a comprehensive examination of social background and
medical history by using a structured questionnaire and
interview, and a collection of all available medical records.
Functional and clinical assessment included a standard
cardiovascular and neurological examination, functional status
measures and a detailed neuropsychological examination. In
the 3-year follow-up, the functional and clinical assessments
will be repeated yearly for all the subjects. This study focused
on the baseline data.
Neuropsychological examination
The neuropsychological test battery of the LADIS Study
included global cognitive tests, the Mini-Mental State
Examination14 and the modified version of the Vascular
Dementia Assessment Scale-cognitive (VADAS-cog),15 with
executive tests, the Stroop test16 and the trail making test.17
The methods were carefully selected and instructed to be suited
for multicentre use.18 In this study, we focused mainly on
measures of mental speed, attention and executive functions.
Specifically, mental speed was assessed with the trail making A
test and the reading and coloured dots sections of the Stroop
test (Stroop parts I and II). Attention and executive functions,
encompassing mental flexibility, set-shifting and response
inhibition, were assessed with the symbol digit modalities
and the digit cancellation subtests of the VADAS-cog, and with
the subtraction scores of the trail making and Stroop tests.
These scores were calculated by subtracting the time taken in
trail making A from the time taken in trail making B (trail
making B2A) and similarly for the Stroop coloured colour-
names and dots (Stroop III2II). Of the VADAS-cog subtests,
the verbal fluency test with animal category was used to assess
executive flexibility and semantic oral skills, and the digit span
backwards test to assess the working memory capacity.
Additionally, the object naming and constructional praxis
(copying geometric forms) subtests from VADAS-cog were
used.
Magnetic resonance imaging
All subjects underwent brain MRI locally at the centre where
they were recruited according to a standard protocol.13 19 The
MRI was performed with a 1.5-T scanner in 10 centres and with
a 0.5-T scanner in one centre. The protocol comprised three-
dimensional high-resolution coronal or sagittal T1-weighted
magnetisation prepared rapid acquisition gradient echo images
(echo time 4–7 ms, repetition time 10–25 ms, field angle 15–
30 ,˚ voxel size 16161 mm3, field of view 250 mm), axial T2-
weighted images (echo time 100–120 ms, repetition time 4000–
6000 ms) and fluid-attenuated inversion recovery images (echo
time 100–140 ms, repetition time 6000–10 000 ms, inversion
time 2000–2400 ms). The images were collected centrally at the
Image Analysis Centre of the Vrije Universiteit Medical Centre
(Amsterdam, The Netherlands). The volume of WMH was
assessed on the fluid-attenuated inversion recovery images by a
single rater using a semiautomated method as detailed earlier.19
The lesions were marked using a seed technique, and local
thresholding was performed on each slice. The total volume of
WMH was calculated automatically after all lesions were
delineated.
The assessment of corpus callosum atrophy was performed in
the Danish Research Center for Magnetic Resonance
(Copenhagen, Denmark), and the procedure has been described
elsewhere.12 In short, the magnetisation prepared rapid
acquisition gradient echo images were stereotactically normal-
ised to a reference T1-weighted image positioned in Talairach
orientation (using SPM2 with a 12-parameter linear affine
transformation) to correct for interindividual variability in
brain size and orientation. For each subject, the results of the
normalisation to parenchymal brain volume were checked
manually by comparing the location of six marker points on the
surface of the brain in relation to the template. By using a
learning-based active appearance model,20 the corpus callosum
was automatically located and segmented on the midsagittal
slice. The total cross-sectional corpus callosum area was
automatically divided into five subregions by rotating and
translating the corpus callosum into a coordinate system in
which the x axis is parallel to the longest axis of the structure
and the y axis passes through the centre of gravity. Radial
dividers from the origo with equal angular spacing were used to
subdivide the corpus callosum into rostrum and genu (CC1),
rostral body (CC2), midbody (CC3), isthmus (CC4) and
splenium (CC5), as shown in fig 1. Finally, the normalised
area of the total corpus callosum and each subregion was
calculated automatically.
Statistical analysis
The relationships between the neuropsychological test
performance and the MRI predictors were analysed mainly
using multiple linear regression in two sets of models. The
CC5
CC4CC3
CC2
CC1
Figure 1 Segmentation of the corpus callosum (CC) subregions from the
mid-sagittal magnetic resonance imaging slice. CC1, rostrum and genu;
CC2, rostral body; CC3, midbody; CC4, isthmus; and CC5, splenium.
492 Jokinen, Ryberg, Kalska, et al
www.jnnp.com
neuropsychological variables were set as outcome variables one
by one. The explanatory variables included age, education,
history of stroke (no v yes), and WMH volume as covariates in
each model. In the first model set, the total corpus callosum
area was added in the explanatory variables to assess the effect
of overall corpus callosum atrophy. Instead, in the second set,
the five regional corpus callosum measures were included to
examine the independent contributions of the corpus callosum
subregions to cognitive performance. All explanatory variables
were entered simultaneously. The total number of linear
regression analyses was 18 (model sets I and II; table 1).
The distributions of the neuropsychological variables were
checked for outliers and non-normality, and, if necessary,
logarithmic transformation was used. Logarithmic transforma-
tion was applied also for WMH volume. Because of substantial
skewness, the two additional tests, object naming and
constructional praxis, were analysed by using logistic regression
after these variables were turned into dichotomous variables
(errors v no errors). These logistic regression analyses were
otherwise identical with the above-mentioned linear regression
models with the same explanatory variables and simultaneous
entry method.
The results were also calculated by controlling for sex,
handedness, number of lacunar infarcts, and presence of
hypertension and diabetes, but these factors were not included
in the final analysis, because the significant results remained
unchanged. The proportion of missing values in the neuro-
psychological variables varied from 0.7% to 5.3%, and no
replacement was used. Because of multiple analyses, the
criterion for significance was set as p,0.01.
RESULTS
Table 2 gives the characteristics of the study sample. According
to the visual rating scale,13 254 (45%) of the subjects had mild,
177 (31%) moderate and 136 (24%) severe WMH. The Pearson’s
correlation between total corpus callosum area and WMH
volume was 20.33, p,0.001, and that between the corpus
callosum subregions 0.51–0.83, p,0.001. Descriptive figures
and correlations of the WMH volume and corpus callosum area
in the LADIS subjects have been reported in more detail
elsewhere.12 19 Of the 163 subjects who had a history of stroke,
131 (82%) had one stroke event, 25 (16%) had two and 4 (3%)
had .2 stroke events (disregarding three cases with missing
data). The severity of stroke was minor in 146 (90%) subjects
and major in 16 (10%). Furthermore, according to the trial of
ORG 10172 in acute stroke treatment criteria,21 70 (44%) of the
subjects with stroke history had lacunar infarcts, 38 (24%) had
large-artery atherosclerosis, 14 (9%) had cardioembolism, and
36 (23%) had other or undetermined causes.
The linear regression analyses adjusted for age, education,
history of stroke and WMH volume showed that the total
corpus callosum area significantly predicted performance in the
trail making A test, the Stroop test parts I and II, and in the
verbal fluency test (model I in table 1). Furthermore, otherwise
identical analyses but with the corpus callosum subregions as
explanatory variables showed that CC1 (rostrum and genu) was
the only subregion to independently predict the subtraction
scores in the trail making test (B2A) and the Stroop test
(III2II), as well as the number of correct responses in the
symbol digit modalities and digit cancellation tests (model II in
table 1). In addition, verbal fluency was predicted by CC4
(isthmus) area. All the significant results were in the expected
direction—that is, a small corpus callosum area predicted poor
cognitive performance.
The total explanatory power (R2) in model I ranged from 0.13
to 0.33 and that in model II from 0.14 to 0.34. Of the covariates,
age and education were significantly associated with cognitive
performance in both models: age predicted trail making A,
B2A, Stroop III–II, symbol digit modalities, digit cancellation
and verbal fluency (standardised b coefficients 0.10–0.17,
p,0.01), and education predicted all cognitive variables
(0.22–0.47, p,0.001). History of stroke had no significant
incremental contribution to cognitive performance. WMH
volume significantly predicted trail making A (0.16, p,0.001),
B2A (0.16, p,0.001), Stroop I (0.15, p,0.001), Stroop II (0.20,
p,0.001), symbol digit modalities (–0.20, p,0.001), digit
cancellation (–0.26, p,0.001) and verbal fluency (–0.16,
p,0.001), when controlling for the other covariates and the
total corpus callosum area. Despite fairly strong correlations
between the explanatory MRI variables (see above), no
excessive multicollinearity in the regression models was found.
The VADAS-cog naming objects and constructional praxis
subtests reflecting primarily posterior cognitive functions were
analysed with logistic regression analysis by using the same
explanatory variables and covariates and identical model sets.
Neither the total corpus callosum area nor any of the corpus
callosum subregions significantly predicted performance in
these tasks. The odds ratios varied between 0.990 and 1.009.
DISCUSSION
We investigated the role of regional and overall corpus callosum
atrophy in cognitive deficits in a large sample of subjects with
Table 1 Relationship of corpus callosum atrophy to cognitive functioning
Corpus callosum area
Model I Model II
CC total CC1 CC2 CC3 CC4 CC5
Trail making A, time –0.13* –0.16 –0.01 0.00 0.12 –0.10
Trail making B–A, time –0.03 –0.31** –0.08 0.17 0.02 0.18
Stroop part I, time –0.13* 0.06 0.07 –0.10 0.03 –0.22
Stroop part II, time –0.13* –0.01 –0.02 –0.01 –0.02 –0.10
Stroop part III–II, time –0.03 –0.22* 0.12 0.05 0.00 0.03
Symbol digit modalities, correct 0.09 0.20* 0.04 –0.07 –0.03 –0.06
Digit cancellation, correct 0.05 0.21* 0.08 –0.12 –0.02 –0.10
Digit span backwards 0.07 0.19 0.12 –0.15 –0.01 –0.08
Verbal fluency 0.14** 0.12 –0.06 –0.09 0.18* 0.01
CC, corpus callosum; CC1, rostrum and genu; CC2, rostral body; CC3, midbody; CC4, isthmus; CC5, splenium.
Values are standardised b coefficients of linear regression models expressing the independent predictive values of CC measures to neuropsychological test performance,
when controlling for age, education, history of stroke and volume of white matter hyperintensities. Model I includes total CC area, whereas model II includes the five CC
subregions.
*p,0.01.
**p,0.001.
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age-related WMH. The results point out several novel findings.
Atrophy in the most anterior parts of the corpus callosum
(rostrum and genu) was independently associated with poor
performance in neuropsychological tests assessing attention
and executive functions and covering mental flexibility and
response inhibition. These deficits possibly reflect a relatively
focal dysfunction of the prefrontal cortices and their related
subcortical circuits. Moreover, atrophy of the total corpus
callosum area was associated with poor performance in tests of
mental processing speed. This in turn could indicate a diffuse
effect possibly reflecting overall subcortical damage and
disconnection between the cerebral cortices.
Previous studies have shown that executive deficits and
attention are related to the degree of WMH22 and frontal
cortical atrophy,23 but to date, the role of corpus callosum
atrophy in these deficits has been poorly understood. One of the
few studies investigating specific executive functions in the
elderly found that subjects with a higher corpus callosum
atrophy rating had lower scores in trail making B, digit symbol
and a letter-based fluency test.2 The role of corpus callosum
atrophy in executive functions is of particular interest, as it has
been postulated that complex tasks require more efficient
interhemispheric cooperation than simpler tasks.24 The anterior
region of the corpus callosum is believed to be involved in the
transfer of attentional resources and higher cognitive informa-
tion, and posterior regions in transfer of basic sensory
information.24 Further, functional imaging studies provide
evidence for bilateral frontal lobe involvement in executive
processing.25
In this study, performance in a category-based verbal fluency
task was not predicted by the anterior corpus callosum area, as
was expected, but by the total corpus callosum and the CC4
(isthmus) subregion. This was the only cognitive measure that
was significantly related to any region other than the most
anterior subregion in multivariate analysis. Although the
category fluency task assesses flexible searching strategies—
that is, executive control—it also requires semantic knowl-
edge,26 possibly mediated by the posterior cerebral cortices.
Previous studies investigating the association between corpus
callosum atrophy and verbal fluency performance in various
patient groups have provided diverse results. Some studies have
found a relationship between corpus callosum atrophy and
verbal fluency,2 whereas others have not.10 27
Executive functions, as an umbrella term, can be defined as
‘‘a set of cognitive skills that are responsible for the planning,
initiation, sequencing, and monitoring of complex goal-directed
behaviour’’.28 The methods of assessing executive functions are
generally highly multifactorial, and therefore, although they are
sensitive to frontal lobe damage, performance in these can be
impaired also for other (non-frontal) reasons.28 29 In this study,
attention and executive functions were evaluated by using
widely studied and established tests, the Stroop, trail making,
symbol digit modalities, digit cancellation and verbal fluency
tests. It was found that most of the complex attentional and
executive tasks were related to anterior, but not overall corpus
callosum atrophy. Instead, the speed measures were related to
overall, but not regional corpus callosum atrophy. Notably, task
difficulty can be one factor explaining the observed dissociation
between executive deficits and mental slowing.
Two additional tests assessing ability to name objects and
copy geometrical figures were also analysed to cover functions
that are assumed to rely mainly on the integrity of the more
posterior brain areas. It was found that, after controlling for
age, education, history of stroke and WMH volume, none of the
corpus callosum measures was significantly associated with
performance in these tasks. However, because of skewed
distributions, the analyses may have been less sensitive than
the previous ones.
In this study, the role of corpus callosum atrophy was
examined in multivariate analysis by adjusting for demographic
factors, and coexisting WMH and stroke. Still, a relatively large
proportion of variance in cognitive performance remained
unexplained by the models. In general, education had the
strongest predictive value for cognitive performance above all
explanatory variables, followed by WMH, corpus callosum
measures and age. History of stroke had no independent
predictive value for cognitive functions, incrementally to the
other explanatory variables, which could be explained by the
low frequency of major strokes in the sample. It should be
noted that all corpus callosum subregions were entered
simultaneously into the multivariate models as explanatory
variables, which could lead to underestimation of their
individual contributions owing to substantial mutual correla-
tions. On the other hand, the possibility of a false positive error
was minimised and robust independent contributions were
identified.
One of the strengths of the present study is the large sample
size that represents a mixed population of elderly subjects with
a broad range of WMH (from mild to severe). The subjects were
enrolled in the study on the basis of various referral reasons
reflecting the diversity of clinical manifestations related to
vascular brain pathology. Previous studies have investigated the
relationship of corpus callosum atrophy to cognition, mainly in
small patient samples, and have largely concentrated on
Alzheimer’s disease. As the sample extensively covered all
degrees of WMH, the cases with severe WMH may have driven
the results more than expected in a population-based sample.
Another advantage of the study is the sophisticated
quantitative MRI analysis that provides accurate measures of
corpus callosum morphology and WMH load. Volumetric
analysis of WMH has proved to be more sensitive than the
visual rating scales, with a potential ceiling effect.19 WMH
volume was not corrected for overall intracranial volume.
However, controlling for sex, which could be expected to
account for much of the interindividual variability in brain size,
did not have any effect on the results. A previous study found
no relationship between WMH volume and brain size indepen-
dently of sex.30
We did not analyse the topography of the coexisting brain
lesion, such as WMH, stroke or brain atrophy. Importantly,
regional cortical atrophy was not controlled for in our analyses,
and thus, it is conceivable that the corpus callosum measures
reflect cortical atrophy, explaining part of the observed
cognitive deficits. Earlier studies have suggested that, in
Alzheimer’s disease, the pattern of corpus callosum atrophy
reflects the corresponding regional cortical neuronal loss,
possibly resulting from a degeneration of axons of pyramidal
Table 2 Characteristics of the subjects (n = 567)
Age (years) 74 (5)
Sex, women* 312 (55)
Education (years) 9.7 (3.8)
MMSE 27.4 (2.4)
Stroke present* 163 (29)
WMH volume (cm3) 21.2 (22.8)
Total CC area (mm2) 642 (134)
CC1 180 (40)
CC2 94 (25)
CC3 91 (24)
CC4 92 (27)
CC5 185 (40)
Values are means (SD) or n (%)*
CC, corpus callosum; CC1, rostrum and genu; CC2, rostral body; CC3,
midbody; CC4, isthmus; CC5, splenium; MMSE, Mini-Mental State
Examination; WMH, white matter hyperintensities.
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neurones in cortical layer III.6 7 However, in the present study,
the corpus callosum measures were corrected for parenchymal
volume by means of a spatial normalisation procedure, which
adjusts for brain size and thereby for major global atrophy. In
the elderly, there are probably several mechanisms behind
corpus callosum atrophy. Besides cortical atrophy, other
possible factors could be axonal disruption due to vascular
lesions such as stroke, WMH or changes in the normal-
appearing white matter.
In conclusion, in cross-sectional analysis, corpus callosum
atrophy seems to contribute to cognitive decline in the elderly,
not only as an indirect manifestation of subcortical white
matter lesions but possibly also as an indicator of reduced
functional connectivity between cortical areas. It may also serve
as a surrogate marker for regional cortical neuronal loss.
Anterior corpus callosum atrophy seems to have a role in the
frontal-lobe-mediated executive functions and attention,
whereas overall corpus callosum atrophy is associated with
the slowing of processing speed. Further studies are required to
establish the clinical significance of corpus callosum atrophy
longitudinally. Moreover, regional analysis of concomitant
brain pathology will give further insight into the pathophysio-
logical mechanisms leading to corpus callosum atrophy.
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